Wednesday, January 3, 2018

Critical Diagnostics Raises $8.5M For Cardiac Assays

San Diego-based Critical Diagnostics has raised $8.5M in a funding round, the company said on Wednesday. The company develops cardiac biomarker tests used by physicians to assess heart failure patients. Names of the specific investors in the round were not announced, however, the company said it came from a "consortium of industry-related investors". Critical Diagnostics said the proceeds will be used for global commercialization efforts.

---